Article Listing - IDEC's Zevalin for NHL becomes first approved radioimmunotherapy in USA

NEOZYME CORP

10 February 1992

Greg Phelps is named as president of Neozyme Corporation. He replaces Elliott Hillback, who will remain a director.

SMITHKLINE BEECHAM PROMOTIONS

10 February 1992

SmithKline Beecham has announced the appointment of Richard Torrenzano as director and senior vice president for corporate affairs.

ROCHE PROMOTIONS

10 February 1992

Claude Schreiner has been named as president of Produits Roche and Societe Chimique Roche.

BULGARIA'S MEDICA LTD

10 February 1992

Medica Ltd of Bulgaria is seeking foreign partners for business cooperation. Medica is a joint stock company involved in the...

US HEALTH CARE ISSUES IN BUSH SPEECH TO NATION

10 February 1992

President Bush's proposal in his State of the Union message to make the 20% tax credit on incremental R&D spending...

NEW CHEMICAL ENTITIES UPDATE FOR 1991

10 February 1992

1991 was an interesting year in terms of New Chemical Entities, with a number of products of blockbuster potential coming...

UPSA DEAL TO SELL TO THE UKRAINE

10 February 1992

French drugmaker Laboratoires UPSA is in the running to be an early commercial partner in the new Commonwealth of Independent...

EARNINGS DOUBLE AT R-P RORER

10 February 1992

Franco-American pharmaceutical concern Rhone-Poulenc Rorer reported last week that its net income for 1991 had doubled, compared with 1990 figures...

BUSH SEEKS $797 MILL FOR FDA IN 1993

10 February 1992

The Bush Administration budget request for the US Food and Drug Administration for fiscal 1993 totals $797 million, which is...

US HOSPITALS FEAR DISCOUNT "DISASTER"

10 February 1992

An average hospital in the USA could have to pay $389,000 more each year, or an increase of 23.4%, to...

Showing 94821-94830 of 95360 articles

Go to beginningPreviousNextGo to end